Trial NCT03693846

View at ClinicalTrials.gov 
Org. Study IDs: UPCC 28218

Last trial update was posted on 2022-10-20

MeSH Interventions

Ipilimumab Nivolumab

MeSH Conditions

Adenocarcinoma Adenocarcinoma, Mucinous Appendiceal Neoplasms Cystadenocarcinoma

Other Conditions

Mucinous Adenocarcinoma of the Colon Mucinous Adenocarcinoma of the Rectum

Stopping Reasons

Terminated due to slow enrollment and lack of efficacy

Limitations And Caveats

Early termination leading to small numbers of subjects analyzed.

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID